VACCINE HAVRIX ADULT HEPATITIS A 1ML EACH

Code: 13111-SK

AU$54.00
  • 5 - AU$51.57 per EACH
  • 20 - AU$48.82 per EACH
  • 100 - AU$46.80 per EACH
EACH (1)

HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV.

 

Specifications

Specifications

 

Download Consumer Medicine Information.

Download Australian Product Information.

Each 1.0 mL monodose vial or pre-filled syringe contains: 1440 ELISA units of inactivated hepatitis A virus (HM175 strain) & 0.5 mg aluminium as aluminium hydroxide hydrate.

Also contains traces of: formaldehyde, neomycin & polysorbate 20.

McFarlane News and Offers

* indicates required

 

MCFARLANE


U14 / 100 New St
Ringwood VIC 3134

ABN 73 006 561 002

Phone 1300 174 961

O/seas 61 3 9836 7777
 

INFORMATION
CUSTOMER SERVICE

© , McFarlane Medical All rights reserved.

To top